文献速递心脑血管急症

钙释放缺乏综合征的临床诊断试验

A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome.
PubMed 文献 · JAMA · 2024-01-01
一句话结论短阵心动过速后暂停时T波振幅变化在CRDS患者中显著大于对照,最小变化0.250 mV vs 对照最大0.160 mV,实现100%区分。

这项国际多中心病例对照研究纳入10例CRDS患者、45例疑似室上性心动过速对照、10例不明原因心脏骤停幸存者对照和3例基因型阳性CPVT对照,评估短阵心动过速(心室率≥150次/分)后暂停时心电图复极反应。CRDS患者暂停后窦性搏动T波振幅变化中位数更高(P<.001),最小变化0.250 mV vs 对照最大变化0.160 mV,区分度100%;QT间期变化中位数也更长(P=.002)但存在重叠。基因小鼠模型重现了人类发现,提示复极反应继发于肌浆网病理性大量收缩期钙释放。作者认为若在更大研究中证实,这一易操作手法可能成为CRDS的有效临床诊断试验。

要点

  • CRDS患者短阵心动过速(≥150次/分)后暂停时T波振幅变化中位数高于对照(P<.001),最小变化0.250 mV vs 对照最大0.160 mV,区分度100%。
  • QT间期变化中位数在CRDS患者中更长(P=.002),但病例与对照存在重叠。
  • 该试验采用短暂心动过速后暂停(自发性或经心脏起搏介导),操作简便。
  • 基因小鼠模型重现人类复极反应,提示继发于肌浆网病理性大量收缩期钙释放。
  • 作者认为若在更大研究中证实,该手法可能成为CRDS的有效临床诊断试验,并成为心脏骤停评估的重要部分。

适用人群与场景

  • CRDS病例患者10例;对照包括疑似室上性心动过速患者45例、不明原因心脏骤停幸存者10例、基因型阳性CPVT患者3例。
  • 研究在7个国家10个中心进行,患者心电图记录于2005年6月至2023年12月。

诊断标准与关键阈值

  • 诊断试验:短阵心动过速(心室率≥150次/分)后暂停(自发性或经心脏起搏介导),测量暂停后窦性搏动与心动过速前最后一搏的QT间期绝对值和T波振幅绝对值之差。
  • CRDS患者T波振幅变化最小为0.250 mV,对照患者最大为0.160 mV,以此实现100%区分。

研究设计与关键结果

  • 国际多中心病例对照研究:10例CRDS、45例疑似室上速对照、10例不明原因心脏骤停对照、3例基因型阳性CPVT对照,短阵室速≥150次/分后暂停,CRDS患者T波振幅变化中位数更高(P<.001),最小变化0.250 mV vs 对照最大0.160 mV,区分度100%。
  • CRDS患者QT间期变化中位数更长(P=.002),但病例与对照存在重叠。
  • 基因小鼠模型(CRDS、野生型、CPVT)重现人类复极反应,提示继发于肌浆网病理性大量收缩期钙释放。

证据类型、等级与局限

  • 证据类型:国际多中心病例对照研究,包含基因小鼠模型机制探索。
  • 局限:原文未报告局限性;作者结论指出需在更大研究中证实(If these findings are confirmed in larger studies)。

对床旁实践的改变

  • 作者认为若在更大研究中证实,这一易操作手法可能成为CRDS的有效临床诊断试验,并成为心脏骤停评估的重要部分。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: Sudden death and cardiac arrest frequently occur without explanation, even after a thorough clinical evaluation. Calcium release deficiency syndrome (CRDS), a life-threatening genetic arrhythmia syndrome, is undetectable with standard testing and leads to unexplained cardiac arrest.

OBJECTIVE: To explore the cardiac repolarization response on an electrocardiogram after brief tachycardia and a pause as a clinical diagnostic test for CRDS.

DESIGN, SETTING, AND PARTICIPANTS: An international, multicenter, case-control study including individual cases of CRDS, 3 patient control groups (individuals with suspected supraventricular tachycardia; survivors of unexplained cardiac arrest [UCA]; and individuals with genotype-positive catecholaminergic polymorphic ventricular tachycardia [CPVT]), and genetic mouse models (CRDS, wild type, and CPVT were used to define the cellular mechanism) conducted at 10 centers in 7 countries. Patient tracings were recorded between June 2005 and December 2023, and the analyses were performed from April 2023 to December 2023.

INTERVENTION: Brief tachycardia and a subsequent pause (either spontaneous or mediated through cardiac pacing).

MAIN OUTCOMES AND MEASURES: Change in QT interval and change in T-wave amplitude (defined as the difference between their absolute values on the postpause sinus beat and the last beat prior to tachycardia).

RESULTS: Among 10 case patients with CRDS, 45 control patients with suspected supraventricular tachycardia, 10 control patients who experienced UCA, and 3 control patients with genotype-positive CPVT, the median change in T-wave amplitude on the postpause sinus beat (after brief ventricular tachycardia at ≥150 beats/min) was higher in patients with CRDS (P < .001). The smallest change in T-wave amplitude was 0.250 mV for a CRDS case patient compared with the largest change in T-wave amplitude of 0.160 mV for a control patient, indicating 100% discrimination. Although the median change in QT interval was longer in CRDS cases (P = .002), an overlap between the cases and controls was present. The genetic mouse models recapitulated the findings observed in humans and suggested the repolarization response was secondary to a pathologically large systolic release of calcium from the sarcoplasmic reticulum.

CONCLUSIONS AND RELEVANCE: There is a unique repolarization response on an electrocardiogram after provocation with brief tachycardia and a subsequent pause in CRDS cases and mouse models, which is absent from the controls. If these findings are confirmed in larger studies, this easy to perform maneuver may serve as an effective clinical diagnostic test for CRDS and become an important part of the evaluation of cardiac arrest.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Ni M, Dadon Z, Ormerod JOM, et al. A Clinical Diagnostic Test for Calcium Release Deficiency Syndrome. JAMA. 2024. PMID: 38900490. doi:10.1001/jama.2024.8599

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。